Cannabis Cheri

NOVEMBER 27, 2018

Applied topically, cannabis can bring relief to a host of issues including aches and pains, inflammation, itching, rashes, skin conditions like acne, eczema, and psoriasis, skin cancers, and much more. We currently have little data and science to go on as to optimal topical dosages.

Topical 188

Topical Oil Marijuana THC 188

The Cannigma

JUNE 15, 2021

However, the scientific data on CBG is nowhere near as developed as what we have on CBD. Charlotte’s story was featured on CNN in 2013 and millions of people saw with their own eyes how a few drops of cannabis oil succeeded where no other epilepsy treatment had —- reducing her seizures from 300 each week to less than three a month.

CBD 122

CBD Research and Development Epilepsy Extraction 122

Veriheal

SEPTEMBER 14, 2021

While the pool of study subjects could have been larger, researchers were satisfied with the data they gathered from 3,119 respondents. All respondents identified as American military veterans, and the information was pulled from a 2012–2013 National Epidemiologic Survey on Alcohol and Related Conditions–III (NESARC-III). .

Consumption 98

Consumption Research and Development Treatment Programs 98

Medicinal Genomics

NOVEMBER 12, 2024

Many people claim to have Type II plants still alive today that predate the 2013 filing of the patent. By placing the sequence of a Type II plant public, we can help enable the community to sequence their documented Pre-2013 Type II plants. 2)The plant should have a history that predates 2013.

Hash 98

Hash Terpenes Data Extraction 98

Veriheal

DECEMBER 24, 2021

One of the original authors of the Compassionate Use of Medical Cannabis Pilot Program Act in 2013 (MCPP) — a law that led to the legalization of pharmaceutical-grade cannabis across the state of Illinois — says that growing demand and acceptance of the federally illegal plant has not reduced the risk of job loss.

Legislation 98

Legislation Recreational Patients Cannabis 98

The Cannigma

OCTOBER 9, 2021

The overall effects appear to be a reduction in inflammation, sensory activity and bladder contractility, resulting in prolonged bladder emptying of varied significance (Hedlund, 2013). According to the National Association of Incontinence, approximately 25 million Americans are suffering from episodes of involuntary loss of urine.

Consumption 98

Consumption Cannabinoids Patients Cannabis 98

Greencamp

SEPTEMBER 12, 2018

In a 2013 study, it was noted that the endocannabinoid system , and particularly its CB2 receptor, has potential therapeutic properties for managing autism. In a 2015 statement, the Canadian Pediatric Society said that “there is little data to support either the efficacy or safety of cannabis use for any indications in children.”.

Strains 76

Strains Research and Development Marijuana Therapy 76

Otherside Farms

JULY 4, 2022

In treating depression and anxiety, CBG and CBC may be more effective than CBD and THC, but further research is needed to back up the growing body of anecdotal data. Has the Potential to Improve Neurological Condition. Pain and Inflammation. CBC has to get shown to be effective in the management of pain.

Research and Development 96

Research and Development Cannabinoids THC Concentrates 96

The Joint Blog

DECEMBER 18, 2019

– Colorado county-level data show OTC sleep aid sales decline with recreational cannabis access, especially for diphenhydramine and doxylamine. . These findings support survey evidence that many individuals use cannabis to treat insomnia, although sleep disturbances are not a specific qualifying condition under any U.S.

Sleep 49

Sleep Legalization Marijuana Recreational 49

Cannabis Law Report

MARCH 29, 2020

triggering new innovations and improved data quality through better user experiences. o Medical conditions: A panel of doctors must be present at the time of any product research to ensure no adverse effects lessen or damage the health of participants.

Compliance 69

Compliance Compliance Supply Chain Research and Development 69

The Cannigma

OCTOBER 25, 2021

In 2018 Canada legalized recreational cannabis use, becoming the first G7 country to do so and only the second country after Uruguay, which legalized cannabis in 2013. Canadian law allows people to receive medical cannabis for any condition or symptoms approved by their personal healthcare practitioner. per gram, as opposed to $5.73

Legalization 105

Legalization Packaging Edibles Retail 105

Cannabis Law Report

SEPTEMBER 22, 2019

The Concord Monitor reports… A push to have the state join others that have legalized recreational use of the drug fizzled, as did efforts to expand the qualifying conditions for the state’s medical marijuana program and to allow patients to grow their own supply. New Hampshire legalized medical marijuana in 2013.

Conditions 40

Conditions Patients Decriminalization Programs 40

Cannabis Cheri

NOVEMBER 27, 2018

Applied topically, cannabis can bring relief to a host of issues including aches and pains, inflammation, itching, rashes, skin conditions like acne, eczema, and psoriasis, skin cancers, and much more. We currently have little data and science to go on as to optimal topical dosages.

Topical 100

Topical Oil Marijuana THC 100

CannaTech

OCTOBER 14, 2018

The state was well-positioned to permit this type of farming back in 2013 when Senate Bill 566 was enacted, conditionally approving an industrial hemp pilot program. billion by 2022, according to New Frontier Data, a premier cannabis data analytics firm. In the U.S. The approval of SB 1409 should help steer the remaining U.S.

Hemp 53

Hemp Research and Development Agriculture Seed-To-Sale 53

The Joint Blog

FEBRUARY 13, 2020

We think there is a lot of overlap between conditions for which medical marijuana can be used in managing symptoms and the types of illnesses that lead people to file workers’ compensation claims,” said study coauthor, Catherine Maclean, an associate professor in the economics department at Temple University in Philadelphia.

Access 32

Access Marijuana Data Policy 32

Canna Care Docs

JULY 29, 2019

She said it “just barely covers the pain” of her condition. A recently released study out of New York University, supported by the National Institute on Drug Abuse, looked at data from the National Survey on Drug Use and Health, an annual survey of 70,000 Americans of all ages. Around Christmastime last year, Ms.

Chronic Pain 53

Chronic Pain Sleep Education Patients 53

Cannabis Law Report

DECEMBER 17, 2021

Legal, regulatory, business and financial diligence will need to be satisfactorily completed by both the Company and Cova, as well as other customary conditions and approvals. Founded in 2013 and based in Lafayette, Louisiana, Waitr operates an online ordering technology platform, providing delivery, carryout and dine-in options.

Compliance 52

Compliance Compliance Dispensary Seed-To-Sale 52

Healer

JANUARY 17, 2022

People with health conditions for which early research into CBG is showing favorable results, with support and direction from their healthcare providers. As research grows we’ll learn more about the therapeutic potential of CBG in infectious conditions. People who find CBD and/or CBDA too mentally stimulating. CBG vs. CBD.

Cannabinoids 52

Cannabinoids Nerve Pain Research and Development CBD 52

Healer

JANUARY 17, 2022

People with health conditions for which early research into CBG is showing favorable results, with support and direction from their healthcare providers. As research grows we’ll learn more about the therapeutic potential of CBG in infectious conditions. People who find CBD and/or CBDA too mentally stimulating. CBG vs. CBD.

Cannabinoids 52

Cannabinoids Nerve Pain Research and Development CBD 52

Cannabis Law Report

OCTOBER 24, 2021

On June 7, 2013, the federal government implemented the Marijuana for Medical Purposes Regulations (MMPR) 1. At least until there is more historical data and the market landscape normalizes (whatever normal is). Different strains are grown for different purposes under different conditions and can yield very different results.

Strains 52

Strains Extraction Edibles Vaping 52

Cannabis Law Report

FEBRUARY 22, 2019

The initial phase of this activity is aimed at determining and selecting three of more varieties of hybridized hemp strains identified by InPlanta for testing in the specific ecological conditions found in Cambodia. This phase is underway and will be completed before the end of February.

Hemp 40

Hemp Research and Development Hybrid Environment 40

Cannabis Law Report

NOVEMBER 24, 2021

Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. We also used manifest textual analysis to search for word frequencies, and specific conditions referred to in the articles retrieved. At the same time, the outlook on cannabis research data is largely positive.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

JANUARY 20, 2022

Founded in 2013, Eleusis is dedicated to transforming psychedelics into medicines. The transaction is expected to close in the second or third quarter of 2022, subject to customary closing conditions, including the receipt of regulatory approvals and approval by SPKB’s shareholders. About Eleusis.

Therapy 40

Therapy Research and Development Business Access 40

Cannabis Law Report

JUNE 30, 2019

Lou Correa (D-CA) that would require the VA to conduct clinical trials on the therapeutic potential of cannabis in the treatment of such service-related conditions as post-traumatic stress disorder and chronic pain. The panel also took up a bill sponsored by Rep.

Chronic Pain 40

Chronic Pain Legislation Treatment Programs 40

Cannabis Law Report

SEPTEMBER 19, 2019

Right now, there is only a handful of conditions that doctors will consider treating with cannabis, including multiple sclerosis, epilepsy and to help alleviate the effects of chemotherapy treatment. The firm was founded in 1998 and listed on AIM in 2001 before it left London to join the NASDAQ in 2013.?Over GW Pharmaceuticals?is

Pharmaceutical 40

Pharmaceutical Research and Development Medicine Oil 40

Cannabis Law Report

OCTOBER 12, 2021

In 2013 after divesting of the As Seen on TV brand, Kevin joined the board of directors of an emerging start-up in the functional beverage space; Celsius Holdings Inc. He has worked with amazing celebrities like Billie Mays , Tony Little , Jack Lalanne , and George Foreman to name a few.

Extraction 52

Extraction Business Hash Legislation 52

Cannabis Info

JULY 12, 2019

CBD for Pets Yes the Data says it works ! Plus, many of the conditions we’ll list below (like anxiety, arthritis , pain, and convulsions) manifest much in the same way in pets as they do in humans. Lets review some data. News of CBD’s natural anticonvulsant properties first broke in 2013 with the story of Charlotte Figi.

Pets 45

Pets Data CBD Cannabinoids 45

The Cannigma

MARCH 29, 2021

A 2013 comprehensive published in Frontiers in Psychology looked at CBD’s ability to offset the “adverse psychological effects of THC,” and concluded that “the few studies that exist on the effects of CBD show that this cannabinoid can counteract some of the negative effects of THC.”. Cardiac-related mortality data from the U.S.

Blood Pressure 145

Blood Pressure Indica THC Strains 145

Cannabis Law Report

OCTOBER 29, 2019

The PK data on cats shows there are differences in absorption between cats and dogs and that dosing may be different between these two species and that our chew form is likely to be more absorbable than oils in general. This data gives us confidence in the use of both the chew and the oils as effective means for delivering CBD to your pet.”.

Safety 45

Safety CBD Clinical Trials Oil 45

Cannabis Law Report

MAY 26, 2022

In a more current report from Colorado from the Rocky Mountain HIDTA Training and Information Center (2020), it was reported that since recreational marijuana was legalized in 2013, past month youth (ages 12–17) marijuana use decreased 25% yet is 43% higher than the national average, currently ranked 7th in the nation. 2012, Calabria et al.,

Dispensary 52

Dispensary Research and Development Safety Recreational 52

Cannabis Law Report

JANUARY 9, 2019

Phoenix, headquartered in Denver, distributes medicinal cannabis products around the globe to treat seven major categories of medical conditions including pain, cancer, autoimmune, metabolic, neurological, psychological and sleep disorders. The biggest pushback Phoenix has received until now has been the lack of data, Tindall said.

Therapy 85

Therapy Clinical Trials Treatment Medicine 85

Healer

JUNE 28, 2019

Cannabinoids have neuroprotective effects, protecting the nerves from acute injuries like head trauma and stroke, and from conditions that cause chronic injury, such as Alzheimer’s disease. OBJECTIVE: To determine the efficacy of medical marijuana in several neurologic conditions. ’ Koppel, Barbara S., Abstract: Medical Study .

Cannabinoids 52

Cannabinoids THC Therapy Patients 52

The Cannigma

DECEMBER 1, 2021

In a 2013 book, Marijuana is Safer: So Why Are We Driving People to Drink? Many cannabis skeptics are often surprised to learn that cannabis can represent an effective medicine for diverse conditions and disorders. Your parents may even find that cannabis could help with conditions that affect them.

Research and Development 105

Research and Development Tincture THC Cannabinoids 105

Cannabis Law Report

MAY 29, 2022

FDA granted Breakthrough Therapy designation for Spravato in 2013 and ultimately approved it for adults who have not responded to treatment after trying other antidepressant medications. Fast Track review is for drugs that treat serious conditions and fill an unmet medical need. Approval Pathways.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

SEPTEMBER 14, 2021

WHEREAS, in 2013, simple cannabis possession was the fourth most common cause of deportation for any offense and the most common cause of deportation for drug law violations; and. WHEREAS, in 2018, the ACLU found that extreme racial disparities in cannabis possession arrests persists throughout the country, with the cannabis arrest rate 3.64

Policy 98

Policy Research and Development Access Cannabis 98

StrainConnect

MARCH 9, 2019

In 2004, Dr. Ethan Russo developed the theory that this deficiency might explain the development of certain conditions, such as migraines, irritable bowel syndrome, or fibromyalgia(16). Of course, there is much more to discover, but Dr. Russo´s theory has opened the door to research methods to prevent and manage certain conditions.

Research and Development 42

Research and Development Cannabinoids Sativa CBD 42

Marijuana Packaging

SEPTEMBER 23, 2024

The data showed a 25% drop in deaths from prescription medication between 1999 and 2010 throughout the 13 states that had opted to legalize marijuana. The co-author of this eye-opening study, Colleen Barry, pointed out that it is highly unlikely (if not outright impossible) for a human to consume a fatal amount of marijuana.

Marijuana 40

Marijuana Research and Development Data Legalization 40